Masanobu Minamino - Yakult Honsha Insider
| YKH Stock | EUR 18.80 0.10 0.53% |
Insider
Masanobu Minamino is Managing Executive Officer, Deputy Director of Central Research Institute of Yakult Honsha CoLtd since 2016.
| Tenure | 8 years |
| Phone | 81 3 6625 8960 |
| Web | https://www.yakult.co.jp |
Yakult Honsha Management Efficiency
The company has return on total asset (ROA) of 0.0562 % which means that it generated a profit of $0.0562 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1037 %, meaning that it generated $0.1037 on every $100 dollars invested by stockholders. Yakult Honsha's management efficiency ratios could be used to measure how well Yakult Honsha manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Supawan Sirinuntawit | Bumrungrad Hospital Public | N/A | |
| Esteban Alert | Austevoll Seafood ASA | 71 | |
| Artirat Charukitpipat | Bumrungrad Hospital Public | 55 | |
| Tore Mohn | Austevoll Seafood ASA | 73 | |
| Jeremy Ford | Bumrungrad Hospital Public | N/A | |
| Erling Mgster | Austevoll Seafood ASA | 60 | |
| Daniel Kastner | Bumrungrad Hospital Public | N/A | |
| Linda Lisahapanya | Bumrungrad Hospital Public | 70 | |
| Oraphan Buamuang | Bumrungrad Hospital Public | 49 | |
| Andres Daroch | Austevoll Seafood ASA | 63 | |
| Arne Stang | Austevoll Seafood ASA | 75 | |
| Britt Drivenes | Austevoll Seafood ASA | 60 | |
| Adriana Alva | Austevoll Seafood ASA | 60 | |
| Tom Tynan | Austevoll Seafood ASA | N/A | |
| Rangsima Thongdee | Bumrungrad Hospital Public | N/A | |
| Tanee Maneenut | Bumrungrad Hospital Public | N/A | |
| Henning Beltestad | Austevoll Seafood ASA | 55 | |
| David FACHE | Bumrungrad Hospital Public | N/A | |
| Aniello Sorrentino | Bumrungrad Hospital Public | 76 | |
| Arne Mogster | Austevoll Seafood ASA | 48 | |
Management Performance
| Return On Equity | 0.1 | |||
| Return On Asset | 0.0562 |
Yakult Honsha CoLtd Leadership Team
Elected by the shareholders, the Yakult Honsha's board of directors comprises two types of representatives: Yakult Honsha inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Yakult. The board's role is to monitor Yakult Honsha's management team and ensure that shareholders' interests are well served. Yakult Honsha's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Yakult Honsha's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shuichi Watanabe, Executive Officer | ||
| Susumu Hirano, Managing Executive Officer, General Manager of Subsidiary, Director | ||
| Takao Goto, Executive Officer | ||
| Richard Hall, Director | ||
| Tetsuya Hayashida, Managing Executive Officer, Chief Director of Food Business, Chief Director of Cosmetics Business, Director | ||
| Junichi Shimada, Executive Officer | ||
| Masanobu Minamino, Managing Executive Officer, Deputy Director of Central Research Institute | ||
| Masatoshi Nagira, Managing Executive Officer | ||
| Masayuki Fukuoka, Independent Director | ||
| Hiroyuki Kawabata, Executive Officer | ||
| Akifumi Doi, Managing Executive Officer, Chief Director of Production, Director | ||
| Koichi Hirano, Managing Executive Officer | ||
| Yoshihiro Goto, Executive Officer | ||
| Hiroaki Nagaoka, Executive Officer | ||
| Fumiyasu Ishikawa, Senior Managing Executive Officer, Chief Director of Research & Development, Director of Central Research Institute, Director | ||
| Akira Kishimoto, Executive Officer | ||
| Naoko Tobe, Independent Director | ||
| Yasuyuki Suzuki, Executive Officer | ||
| Takashige Negishi, President Executive President Representative Director | ||
| Masanori Ito, Managing Executive Officer, Chief Director of Medicines Business, Director | ||
| Ryuji Yasuda, Independent Director | ||
| Masahiko Satomi, Executive Officer | ||
| Pascal Petrini, Independent Director | ||
| Masao Imada, Managing Executive Officer, Director | ||
| Yutaka Natsume, Executive Officer | ||
| Hiroshi Narita, Senior Managing Executive Officer, Chief Director of International Business, Chief Director of Business Support, Director | ||
| Norihito Maeda, President of Subsidiary, Independent Director | ||
| Hiroshi Wakabayashi, Senior Managing Executive Officer, Chief Director of Administration, Director | ||
| Masanobu Nanno, Managing Officer | ||
| Masato Nagaoka, Executive Officer | ||
| Hideaki Hoshiko, Managing Executive Officer |
Yakult Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Yakult Honsha a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.1 | |||
| Return On Asset | 0.0562 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 8.48 B | |||
| Shares Outstanding | 156 M | |||
| Shares Owned By Insiders | 18.61 % | |||
| Shares Owned By Institutions | 25.63 % | |||
| Price To Earning | 22.44 X | |||
| Price To Book | 2.71 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Yakult Stock
Yakult Honsha financial ratios help investors to determine whether Yakult Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Yakult with respect to the benefits of owning Yakult Honsha security.